Health TrialsbyHealthPanel

Evaluation of Exosomes Injection in Treatment of Male Androgenetic Alopecia: Clinical and Immunohistochemical Study

ConditionAndrogenetic Alopecia
Trial statusNot yet recruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexMale
Age18-40
SponsorAin Shams University

About this trial

Intradermal injection of exosomes in treatment of male androgenetic alopecia, clinically and using a immunohistochemical marker

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

blood diseases Receiving other treatments History of malignancy or allergic reaction to exosomes

Trial design

Design model

Single group

Treatments tested in this trial

  • Plasma derived exosomes

    Drug

    Exosomes derived from patients' plasma, centrifuged at high speeds multiple times

Treatment groups

15 Participants
are divided into 1 treatment group
Group A: Males 18-40 years old with androgenetic alopeciaExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Terminal to vellus hair ratio improvement

Counting the terminal and vellus hair counts and calculating the ratio, and comparing it between different study sessions and at follow-ups

Time frame
One year

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Ain Shams University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: